Skip to page content

Hepatitis C

Journal Article
Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns
US hepatitis C viral infections among pregnant women grew fastest among White and American Indian/Alaska Native people without a 4-year degree.
Mar 29, 2022
Journal Article
Assessing and Expanding the Evidence Base for Project ECHO and ECHO-Like Models: Findings of a Technical Expert Panel
Building a strong evidence base will help leverage the innovative aspects of EELM by better understanding how, why, and in what contexts EELM improve care access, quality, and delivery, while also improving provider satisfaction and capacity.
Jun 3, 2020
Commentary
Subscription Models for Prescription Drugs: The Motivation, Potential, and Limitations of a New Payment Model
The authors argue that, conceptually, the main advantage of subscription models over traditional prescription drug payment arrangements is that they could reduce some sources of uncertainty in spending for payers and in revenue for manufacturers.
May 21, 2020
Report
Identifying Safety-Net Resources at Health Centers to Prevent Infectious Disease Transmission Resulting from the Opioid Epidemic
This study highlights factors that affect Community Health Centers' ability to reduce infectious disease transmission related to the opioid epidemic.
Jun 18, 2019
Journal Article
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
The 2010 reformulation of Oxycontin to prevent abuse of the drug (by making it crush-proof and therefore impossible to dissolve in liquid) had the unintended effect of driving some users to switch to heroin, which contributed to a dramatic rise in Hepatitis C.
Mar 13, 2019
Commentary
Opioids and a Crisis of Unintended Consequences
The pain medicine OxyContin was reformulated in 2010 to make it more difficult to crush or dissolve. But this had unintended consequences, including a rise in hepatitis C infections as drug abusers switched from taking OxyContin to injecting heroin.
Feb 20, 2019
Blog
State of the Union, OxyContin, Appalachia: RAND Weekly Recap
This weekly recap focuses on insights from RAND after the State of the Union, public-health impacts of reformulating OxyContin, STEM jobs in Appalachia, and more.
Feb 8, 2019
News Release
Reformulation of OxyContin to Discourage Abuse Linked to Higher Rates of Hepatitis C Infections
To discourage drug abuse, the pain medicine OxyContin was reformulated in 2010, making it difficult to crush or dissolve. This led to a large rise in hepatitis C infections as drug abusers switched from OxyContin to injectable heroin.
Feb 4, 2019
Journal Article
The Association Between Implementation Strategy Use and the Uptake of Hepatitis C Treatment in a National Sample
Veterans Health Administration sites that used more ERIC-recommended implementation strategies delivered more evidence-based Hepatitis C treatments.
Jun 6, 2017
Report
Hepatitis C: Understanding factors that influence the physicians' treatment decisions
A study investigating the decisionmaking process undertaken by physicians when prescribing treatment for Hepatitis C and the comparative influence and importance of specific factors and combinations of factors.
Aug 19, 2016
Commentary
Paying for Pricey Medications: Debt Financing Options Could Provide a Solution
A new approach may be needed to finance an emerging breed of expensive but highly effective pharmaceuticals and vaccines. The health care industry could learn from other industry approaches such as equipment leases or supplier-financed credit.
Jun 22, 2015
News Release
Alternative Financing Schemes May Be Needed to Pay for Expensive New Medications
In an era of $1,000-a-pill medications, a new approach may be needed to finance an emerging breed of highly expensive pharmaceuticals and vaccines. Health care could learn from other industries, where it is common for suppliers to encourage investment through approaches such as equipment leases or supplier-financed credit.
Mar 11, 2015
Commentary
Alternative Financing Schemes May Be Needed to Pay for Expensive New Medications
In an era of $1,000-a-pill medications, a new approach may be needed to finance an emerging breed of highly expensive pharmaceuticals and vaccines. Health care could learn from other industries, where it is common for suppliers to encourage investment through approaches such as equipment leases or supplier-financed credit.
Mar 11, 2015
Report
Hepatitis C: A projection of the healthcare and economic burden in the UK
Work presented in this report sought to assess the healthcare and economic burden of the hepatitis C virus (HCV) infection in the United Kingdom using a cohort simulation model.
Jan 11, 2013
Journal Article
Substance Use and Other Risk Factors for Unprotected Sex: Results from an Event-Based Study of Homeless Youth
This study of condom use among homeless youth in Los Angeles County found that a broad range of individual, relationship, and contextual factors play a role in condom use.
Jul 31, 2012
Journal Article
Social, Structural and Behavioral Drivers of Concurrent Partnerships Among African American Men in Philadelphia
African American men view sexual relationships with non-main partners as riskier; concurrent relationships are acceptable and often expected.
Oct 1, 2011
Journal Article
Patient and Provider Characteristics Associated with the Decision of HIV Coinfected Patients to Start Hepatitis C Treatment
A patient's decision to start or defer hepatitis C treatment is influenced by the stage of their disease and by their providers' confidence about the efficacy of hepatitis C treatment.
Sep 1, 2011
Journal Article
Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion and Sustained Virologic Response in HIV Co-Infected Patients
Good mental health may be an indicator of readiness to adhere to treatment for Hepatitis C among individuals who also have HIV.
Jan 1, 2011
Journal Article
Pharmacy Participation in Non-Prescription Syringe Sales in Los Angeles and San Francisco Counties, 2007
California pharmacies are more likely to participate in a voluntary program allowing limited sale of syringes to adults without a prescription if they think syringe access is important for preventing HIV among drug users.
Jan 1, 2010
Journal Article
Three Years After Legalization of Nonprescription Pharmacy Syringe Sales in California: Where Are We Now?
Many California local health jurisdictions with significant numbers of HIV cases have approved disease prevention demonstration projects, which permit limited sale of syringes to adults without a prescription
Jan 1, 2010

1
2
Next

Research conducted by

RAND Health Care